Related Experiment Video
Updated: Aug 8, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule
J E Skonier1, M A Bowen, J Emswiler
1Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
Insights
Researchers identified key residues in activated leukocyte cell adhesion molecule (ALCAM) crucial for binding to CD6. This deepens understanding of the molecular interactions mediating thymocyte adhesion.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The interaction between CD6 and activated leukocyte cell adhesion molecule (ALCAM) is vital for thymocyte adhesion to thymic epithelial cells.
- ALCAM's N-terminal V-like domain binds to CD6's scavenger receptor cysteine-rich domain.
- Previous studies identified six ALCAM residues critical for CD6 binding, all located on a specific face of ALCAM's N-terminal domain.
Purpose of the Study:
- To further investigate and characterize the CD6 binding site on ALCAM.
- To refine the understanding of which ALCAM residues are essential for CD6 interaction.
- To classify ALCAM residues based on their contribution to CD6 binding.
Main Methods:
- Alanine scanning mutagenesis to identify critical residues.
- Construction and testing of ten new ALCAM mutants.
- Receptor binding assays to quantify binding affinities and contributions.
Main Results:
- Three additional ALCAM residues were identified as critical for CD6 binding.
- Mutagenesis experiments provided further insights into the importance of previously studied sites.
- The study allowed for a detailed classification of ALCAM residues based on their role in CD6 binding.
Conclusions:
- The CD6 binding site on ALCAM has been described in greater detail.
- A comprehensive classification of ALCAM residues involved in CD6 interaction has been established.
- This research enhances the understanding of cell adhesion mechanisms in the immune system.
Abstract:
The interaction between CD6 and its ligand activated leukocyte cell adhesion molecule (ALCAM) mediates adhesion of thymocytes to thymic epithelial cells. The extracellular region of ALCAM includes five Ig-like domains, and its N-terminal V-like domain specifically binds to the membraneproximal scavenger receptor cysteine-rich domain of CD6. Previously, six ALCAM residues were identified by alanine scanning mutagenesis to contribute to the interaction with CD6. All of these residues mapped to the predicted A'GFCC'C" face of ALCAM's N-terminal domain. Here we describe the results of experiments designed to further study the CD6 binding site. Other mutagenesis experiments at four previously studied sites were carried out to better understand their importance for the interaction with CD6, and different receptor binding assays were employed to compare the contribution of these and other ALCAM residues to the CD6-ligand interaction. A total of ten new ALCAM mutants were prepared, and three additional residues were identified as critical for CD6 binding. These studies have enabled us to classify ALCAM residues according to their importance for binding and to describe the CD6 binding site in some detail.
Related Concept Videos
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

